Clinical Terminal

Funding & M&A

Rounds, acquisitions, and the investors moving capital across the revenue cycle.

The Deal Sheet · recent rounds & exits

Company
Type
Amount
Date
Waystar ← Iodine
Acquisition
$1.25B *
2026
Candid Health
Series C
$52.5M
Feb 2025
Candid Health
Series B
$29M
Sep 2024
Candid Health
Seed
$18M
2020
R1 ← Phare Health
Acquisition
Undisclosed
2026

* sourced to headline; not independently verified. Source: knowledge_graph.edges_investment + clustered M&A signals.